Echo Therapeutics, Inc.
$3.5 M
Secondary/Follow-On
Sole Book-Runner
Sole Book-Runner
Sole Book-Runner
Sole Book-Runner
Sole Book-Runner
Sole Book-Runner
Sole Book-Runner
Joint Book-Runner
Sole Book-Runner
Sole Book-Runner
Financial Advisor
Sole Book-Runner
Sole Book-Runner